FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

411531001: Short-acting insulin (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2466982015 Short-acting insulin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2473144019 Short-acting insulin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2466982015 Short-acting insulin (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2466982015 Short-acting insulin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2473144019 Short-acting insulin en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2473144019 Short-acting insulin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Short-acting insulin Is a Insulin false Inferred relationship Existential restriction modifier (core metadata concept)
    Short-acting insulin Has disposition Pancreatic hormone (disposition) false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Insulin soluble Is a False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Human insulin 100units/mL injection cartridge (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Human insulin 100iu/mL injection vial (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin lispro 100iu/mL injection vial (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin lispro 100units/mL injection 3mL cartridge (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    insuline lispro 100 unités/mL, stylo prérempli de 3 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Human insulin 100units/mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing short-acting insulin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing insulin lispro and insulin lispro protamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin soluble bovine 100u/mL injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin soluble bovine 100units/mL injection 1.5mL cartridge (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin soluble porcine 100units/mL injection 1.5mL cartridge (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin soluble porcine 100u/mL injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic lispro 25/75 100u/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic lispro 50/50 100u/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 10/90 100u/mL injection solution 1.5mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 10/90 100u/mL injection solution 3mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 10/90 100u/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 20/80 100units/mL injection 1.5mL cartridge (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 20/80 100units/mL injection 3mL cartridge (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 20/80 100units/mL injection 3mL prefilled pen (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 30/70 100u/mL injection solution 1.5mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 30/70 100u/mL injection solution 3mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 30/70 100u/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 30/70 100u/mL injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 40/60 100units/mL injection 1.5mL cartridge (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 40/60 100u/mL injection solution 3mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 40/60 100u/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 50/50 100u/mL injection solution 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 50/50 100u/mL injection solution 1.5mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 50/50 100u/mL injection solution 3mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 50/50 100u/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 50/50 100u/mL injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 15/85 100u/mL injection solution 3mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 15/85 100u/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 15/85 100units/mL injection 5mL vial (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 25/75 100u/mL injection solution 3mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 25/75 100u/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane human 25/75 100u/mL injection solution 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic lispro 25/75 100units/mL injection 3mL cartridge(product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin soluble human 100units/mL injection 5mL vial (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin soluble human 100units/mL injection 1.5mL cartridge (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin lispro 100units/mL injection 1.5mL cartridge (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane porcine 30/70 100units/mL injection 10mL vial (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic isophane porcine 30/70 100units/mL injection 1.5mL cartridge (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Prompt zinc insulin Is a False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin glulisine (substance) Is a False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    insuline aspart 100 unités/mL, flacon de 10 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin aspart 100units/mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic aspart 30/70 100units/mL injection cartridge 3mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing insulin aspart (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin lispro-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing insulin aspart and insulin aspart protamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Human insulin soluble-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Porcine insulin soluble-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing bovine regular insulin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing biphasic insulin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing biphasic isophane insulin porcine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing biphasic isophane insulin human The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing insulin lispro biphasic The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin aspart 100units/mL injection solution 3mL prefilled disposable injection device The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin isophane biphasic human 20/80 100units/ml injection 3ml pre-filled disposable injection device The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin isophane biphasic human 10/90 100units/ml injection 3ml cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin soluble bovine 100units/ml injection 1.5ml cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin isophane biphasic human 15/85 100units/ml injection 5ml vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin soluble bovine 100units/ml injection 10ml vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic aspart 30/70 100units/mL injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    insulina aspartat Is a False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin lispro Is a False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin aspart protamine Is a False Short-acting insulin Inferred relationship Existential restriction modifier (core metadata concept)

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    POSSIBLY EQUIVALENT TO association reference set

    Back to Start